Table 2 Clinical characteristics of AML patients
Parameters | AML (n = 87) |
|---|---|
Gender | |
Male | 39 (45%) |
Female | 48 (55%) |
Mean age (years, range) | 51.6 (16-90) |
FAB | |
M1 | 18 (20.7%) |
M2 | 21 (24.1%) |
M3 | 16 (18.4%) |
M4 | 14 (16.1%) |
M5 | 15 (17.2%) |
Unknown | 3 (3.4%) |
WHO classification | |
AML with t(8;21) | 3 (3.4%) |
APL with t(15;17) | 16 (18.4%) |
AML with inv16 or t(16;16) | 5 (5.7%) |
AML with t(9;11) | 2 (2.3%) |
AML with t(6;9) | 1 (1.1%) |
AML with myelodysplasia-related changes | 27 (31%) |
AML, not otherwise specified (NOS) | 30 (34.5%) |
Unknown | 3 (3.4%) |